Study quality assessment:
Using the Revised Cochrane risk-of-bias tool for randomized trials (RoB 2) [12], two researchers (MK and SK) evaluated the quality of clinical trials independently. Randomization of participants, selective reporting of outcomes, and the presence of missing data were all evaluated.